EWTX
Edgewise Therapeutics Inc
39.20$
-0.9%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| -0.19 | -0.30 | -0.68 | -0.98 | -1.44 | -1.18 | -1.40 | |
| 0.00 | 0.00 | 0.01 | 0.01 | 0.03 | 0.02 | 0.02 | |
| 0.00 | 0.01 | 0.09 | 0.20 | 0.28 | 0.27 | 0.34 | |
| 0.00 | 0.01 | 0.09 | 0.20 | – | – | – | |
| 0.01 | 0.04 | 0.09 | 0.08 | -0.02 | 0.11 | -0.05 | |
| 0.00 | 0.00 | 0.01 | 0.10 | 0.09 | 0.01 | 0.00 | |
| 0.00 | -0.50 | -4.89 | -1.32 | 1.61 | -2.00 | -0.32 | |
| – | – | 3.77 | 2.42 | – | – | – | |
| – | – | – | 0.00 | – | – | – | |
| 0.50 | 2.44 | 3.77 | 2.42 | 0.83 | 2.70 | 1.91 | |
| 0.31 | 1.65 | -1.81 | 0.12 | 1.01 | -0.48 | 0.19 | |
| -0.19 | -0.30 | -0.69 | -1.09 | -1.53 | -1.19 | -1.40 |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.